# FDA Inspection 1277369 - REGENXBIO Inc - July 31, 2025

Source: https://www.keypedia.com/records/fda_inspections/regenxbio-inc/b9541958-cf82-460c-9849-bebd561d12a2
Source feed: FDA_Inspections

> FDA Inspection 1277369 for REGENXBIO Inc on July 31, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277369
- Company Name: REGENXBIO Inc
- Inspection Date: 2025-07-31
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1298212 - 2025-08-04](https://www.keypedia.com/records/fda_inspections/regenxbio-inc/ed288199-5ce9-40ed-b285-9aeb99d3036b)
- [FDA Inspection 1277369 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/regenxbio-inc/90114ee4-77c2-4ab1-b740-60d509d1436d)

Company: https://www.keypedia.com/companies/regenxbio-inc/2ce07f8f-c537-4340-96f8-7a3b2e519f31

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d